We're so sad: Now that Riegel v. Medtronic and Wyeth v. Levine have been decided, we can no longer bill ourselves as "all preemption, all the time!"
We're forced to write about other stuff.
Not so fast!
One of us was giving a talk a few weeks ago, and an audience member posed a good question: How does the new Risk Evaluation and Mitigation Strategy
(
Read more... )